Boaz Weinstein’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Boaz Weinstein’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,236	Closed	-$3.51K	–	299
2024 Q4	$3.51K	Hold	34,236	–	–	﹤0.01%	267
2024 Q3	$1.38K	Hold	34,236	–	–	﹤0.01%	346
2024 Q2	$1.76K	Hold	34,236	–	–	﹤0.01%	370
2024 Q1	$2.06K	Hold	34,236	–	–	﹤0.01%	384
2023 Q4	$1.37K	Hold	34,236	–	–	﹤0.01%	481
2023 Q3	$2.18K	Hold	34,236	–	–	﹤0.01%	550
2023 Q2	$3.12K	Hold	34,236	–	–	﹤0.01%	597
2023 Q1	$3.85K	Hold	34,236	–	–	﹤0.01%	733
2022 Q4	$13.7K	Buy	34,236 +6,603	+24%	+$2.89K	﹤0.01%	778
2022 Q3	$14K	Buy	+27,633	New	+$12.2K	﹤0.01%	984

Other funds holding CTV.WS

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Boaz Weinstein's CTV.WS Position: Q1 2025 in Review

Boaz Weinstein sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 34,236 shares — an estimated $3.51K sold.

Boaz Weinstein first reported a position in CTV.WS in Q3 2022 and held it in 10 quarters. The position peaked at $14K in Q3 2022. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

Boaz Weinstein reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
Boaz Weinstein sold 34,236 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $3.51K.
Boaz Weinstein first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q3 2022 and held it in 10 quarters.
Boaz Weinstein's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $14K in Q3 2022.
1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on Saba Capital Management's 13F filing for Q1 2025, filed 15 May 2025.